Trending

24/7 Market News Snapshot 29 Sept 2023 September 29, 2023

SeaStar Medical Receives FDA Breakthrough Device Designation for its Selective Cytopheretic Device for Cardiorenal Syndrome September 29, 2023

Femasys Momentum continues after Two Announcements the Week September 29, 2023

24/7 Market News Snapshot 28 Sept 2023 September 28, 2023

FDA Grants Baudax Bio Orphan Drug Designation for TI-168 for the Treatment of Hemophilia A with Inhibitors September 28, 2023

Next

Prev

$377.60 $1.24 0.33%

$171.21 $0.52 0.30%

$127.12 $1.14 0.90%

$250.22 $3.84 1.56%

$131.85 $1.28 0.96%

Biopharmaceutical

SIGA Reports Orders of Approximately $138 Million for Oral and IV TPOXX from U.S. Government

by Ben

Biopharmaceutical

Immix Biopharma Announces 100% Overall Response Rate in Ongoing NEXICART-1 Phase 1b/2a Clinical Trial

Artificial Intelligence

Bullfrog AI Challenging its 52-Week High

VirnetX Declares Special $1 Per Share Cash Dividend

Home Category Market News

Market News

SeqLL Enters 2 Year CRADA with the FBI

by Ben

February 7, 2023

(24/7 MARKET NEWS) – SeqLL Inc. (NASDAQ: SQL) stated, this morning, the establishment of a two-year Cooperative Research and Development...

Biopharmaceutical

Palisade Bio keeps Running

by Ben

December 30, 2022

(24/7 MARKET NEWS) – Palisade Bio, Inc. (Nasdaq: PALI) is in the third trading day of a power move. It’s...

Biopharmaceutical

Viking Therapeutics Hits new 52-Week High on positive Madrigal Pharmaceuticals data

by Ben

December 19, 2022

(24/7 MARKET NEWS) – Viking Therapeutics Inc. (NASDAQ: VKTX) shares are running on this morning’s Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) positive...

Biopharmaceutical

Shuttle Pharmaceuticals continues recent Move Higher

by Ben

December 5, 2022

(24/7 MARKET NEWS) – Shuttle Pharmaceuticals Holdings Inc. (NASDAQ: SHPH) is continuing its recent power move trading at $2.79, up...

Biopharmaceutical

FDA Approves Rigel’s REZLIDHI (olutasidenib) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with a Susceptible IDH1 Mutation

by Ben

December 2, 2022

(24/7 MARKET NEWS) – Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) announced, after yesterday’s market close, that the FDAs approved REZLIDHIA (olutasidenib)...

Biopharmaceutical

VIVO System Used in More Than 800 Procedures in U.S. and European Hospitals

by Ben

December 1, 2022

(24/7 MARKET NEWS) – Catheter Precision, Inc. announced, this morning, that more than 800 procedures, utilizing the VIVO System that...

Biopharmaceutical

Creative Medical Technology Announces FDA Clearance of Investigational New Drug Application

by Ben

November 3, 2022

(24/7 MARKET NEWS) – Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) announced, this morning, that the FDA cleared the Company's...